Gara Jalqabaatti › Leukemia Biphenotypicii Hamaa › Ohio

Qorannoo klinikaalii Leukemia Biphenotypicii Hamaa Ohio keessatti

Qorannoo 8 Leukemia Biphenotypicii Hamaa f Ohio keessatti hirmaatuu jiru.

Magaalota Ohio keessatti

Takkalaa qorannoo (Ingiliffa)

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies and Childrens Hospital, Cleveland
fi 2 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

365 Days · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06317662

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Ohio State University, Columbus

Namoota walitti qabaa jiraSadarkaa 1/2

30 Days · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT04065399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies and Childrens Hospital, Cleveland
fi 4 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies and Childrens Hospital, Cleveland
fi 3 dabalataa

Namoota walitti qabaa jiraSadarkaa 1/2

Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

The Ohio State University Wexner Medical Center, Columbus

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Cincinnati Children's Hospital Medical Center, Cincinnati

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06177067

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Gabrail Cancer Center Research,, Canton

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 12 hanga 95 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies, Cleveland
Nationwide Children's Hospital, Columbus

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.